Click image to enlarge
S-PLEX is MSD’s ultra-sensitive assay platform. It can dramatically improve the sensitivity of immunoassays, reducing the lower limit of detection (LLOD) by 10- to 1000-fold over other assay methods. The S-PLEX Human IL-12p70 Assay has the essential components for an ultrasensitive assay that measures IL-12p70 in a single-analyte format. For detailed instructions on running the IL-12p70 assay, please see the product insert in the "Documentation" tab below.
Related Key Terms:
NKSF1, IL-12 subunit p35, IL-12 subunit p40, IL12 p70, p35, Interleukin 12A
-
-
Specifications
-
Kit Contents
-
Documentation
-
References
Application(s)
|
|
Cytokines & Chemokines
,
Immunology/Inflammation
|
|
Analyte(s)
|
|
IL-12p70
|
|
Species
|
|
Human
|
|
Instrument(s)
|
|
SECTOR Imager 2400
,
SECTOR Imager 6000
,
MESO QuickPlex SQ 120
,
MESO SECTOR S 600
,
MESO QuickPlex SQ 120MM
,
MESO SECTOR S 600MM
|
|
Plate Type
|
|
96-well
|
|
Capture Antibody
|
|
Rat monoclonal
|
|
Detection Antibody
|
|
Mouse monoclonal
|
|
LLOD (Sensitivity)
|
|
2.3 fg/mL
|
|
Dynamic Range
|
|
2.3 - 35,000 fg/mL
|
|
Sample Type
|
|
Serum, Plasma, Cell Culture Supernatant
|
|
Recombinant standards
|
|
Expressed in Insect cell line
|
|
Usage Statement
|
|
For Research Use Only. Not for use in diagnostic procedures.
|
|
Storage Condition
|
|
Multi-Component
|
|
Gene ID(s)
|
|
3592
|
|
UniProt ID(s)
|
|
O60595
|
|
Schedule B Code
|
|
3822.19.0000
|
|
Product Description
|
Storage
|
Quantity per Kit
|
S-PLEX Human IL-12p70 Antibody Set
|
2-8 °C
|
1 each (1 plate size)
|
|
Human IL-12p70 Calibrator
|
2-8 °C
|
1 vial (1 vial)
|
|
S-PLEX Coating Reagent C1
|
≤-70 °C
|
1 vial (300 μL)
|
|
S-PLEX Detect D2 (200X)
|
≤-70 °C
|
1 each (50 μL)
|
|
S-PLEX Detect D1 (4X)
|
≤-70 °C
|
1 each (1.7 mL)
|
|
S-PLEX 96-Well SECTOR Plate
|
2-8 °C
|
1 each (1 plate)
|
|
|
2-8 °C
|
1 bottle (50 mL)
|
|
Diluent Assembly 21 (includes Diluent 2 – 8 mL, and Diluent 3 – 8 mL)
|
≤-10 °C
|
1 each (1 each)
|
|
S-PLEX Enhance E1 (4X)
|
≤-10 °C
|
1 each (1.7 mL)
|
|
S-PLEX Enhance E2
|
≤-10 °C
|
1 vial (1.7 mL)
|
|
S-PLEX Enhance E3 (200X)
|
≤-70 °C
|
1 each (50 μL)
|
|
|
RT
|
1 bottle (18 mL)
|
|
|
≤-10 °C
|
1 vial (500 μL)
|
|
Product Description
|
Storage
|
Quantity per Kit
|
S-PLEX Human IL-12p70 Antibody Set
|
2-8 °C
|
1 each (5 plate size)
|
|
Human IL-12p70 Calibrator
|
2-8 °C
|
5 vial (1 vial)
|
|
S-PLEX Coating Reagent C1
|
≤-70 °C
|
1 vial (300 μL)
|
|
S-PLEX Detect D2 (200X)
|
≤-70 °C
|
5 each (50 μL)
|
|
S-PLEX Detect D1 (4X)
|
≤-70 °C
|
5 each (1.7 mL)
|
|
S-PLEX 96-Well SECTOR Plate
|
2-8 °C
|
5 each (1 plate)
|
|
|
2-8 °C
|
1 bottle (50 mL)
|
|
Diluent Assembly 22 (includes Diluent 2 – 40 mL, and Diluent 3 – 40 mL)
|
≤-10 °C
|
1 each (1 each)
|
|
S-PLEX Enhance E1 (4X)
|
≤-10 °C
|
5 each (1.7 mL)
|
|
S-PLEX Enhance E2
|
≤-10 °C
|
5 vial (1.7 mL)
|
|
S-PLEX Enhance E3 (200X)
|
≤-70 °C
|
5 each (50 μL)
|
|
|
RT
|
1 bottle (90 mL)
|
|
|
≤-10 °C
|
1 vial (500 μL)
|
|
Product Description
|
Storage
|
Quantity per Kit
|
S-PLEX Human IL-12p70 Antibody Set
|
2-8 °C
|
5 each (5 plate size)
|
|
Human IL-12p70 Calibrator
|
2-8 °C
|
25 vial (1 vial)
|
|
S-PLEX Coating Reagent C1
|
≤-70 °C
|
5 vial (300 μL)
|
|
S-PLEX Detect D2 (200X)
|
≤-70 °C
|
25 each (50 μL)
|
|
S-PLEX Detect D1 (4X)
|
≤-70 °C
|
25 each (1.7 mL)
|
|
S-PLEX 96-Well SECTOR Plate
|
2-8 °C
|
25 each (1 plate)
|
|
|
2-8 °C
|
5 bottle (50 mL)
|
|
Diluent Assembly 22 (includes Diluent 2 – 40 mL, and Diluent 3 – 40 mL)
|
≤-10 °C
|
5 each (1 each)
|
|
S-PLEX Enhance E1 (4X)
|
≤-10 °C
|
25 each (1.7 mL)
|
|
S-PLEX Enhance E2
|
≤-10 °C
|
25 vial (1.7 mL)
|
|
S-PLEX Enhance E3 (200X)
|
≤-70 °C
|
25 each (50 μL)
|
|
|
RT
|
5 bottle (90 mL)
|
|
|
≤-10 °C
|
5 vial (500 μL)
|
|
Product Inserts
|
|
|
Certificate of analysis
|
|
|
SDS
|
|
|
Title
|
Journal
|
Year
|
|
Galectin-9, a Player in Cytokine Release Syndrome and a Surrogate Diagnostic Biomarker in SARS-CoV-2 Infection
|
|
|
|
Reliability of self-sampling for accurate assessment of respiratory virus viral and immunologic kinetics
|
|
|
|
Cytokine biomarkers in tear film for primary open-angle glaucoma
|
|
|
|
A Pilot Study of Preoperative Single-Dose Ipilimumab and/or Cryoablation in Women with Early-Stage Breast Cancer with Comprehensive Immune Profiling.
|
|
|
|
Effect of Wild-Type Shigella Species and Attenuated Shigella Vaccine Candidates on Small Intestinal Barrier Function, Antigen Trafficking, and Cytokine Release.
|
|
|
|
View All
|
Order Details
Catalog No
Size
Price in USD
Qty
Customer Service/Orders
Scientific/Technical Support
Instrument Support
Company Headquarters